Oncosil Medical Ltd
Research Oncosil Medical Ltd (OSL) on Bullrun: market cap AUD 26.06M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOSL
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 26.06M
- Financial periodFY2025
- RevenueAUD 1.17M
- Revenue growth126.6%
- Net income-AUD 15.10M
- Free cash flow-AUD 12.08M
- Gross margin-92.5%
Valuation Snapshot
latest market cap is AUD 26.06M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 1.17M | -AUD 15.10M | -AUD 12.08M | -92.5% | -1.37 | AUD 5.11M | AUD 69.92K | AUD 3.10M |
| FY2024 | AUD 516.63K | -AUD 12.38M | -AUD 11.32M | -192.2% | -2.23 | AUD 4.50M | AUD 70.67K | AUD 4.59M |
| FY2023 | AUD 367.68K | -AUD 11.34M | -AUD 11.37M | -332.1% | -3.76 | AUD 9.39M | AUD 170.81K | AUD 9.88M |
| FY2022 | AUD 231.79K | -AUD 10.73M | -AUD 10.12M | -319.6% | -4.03 | AUD 11.28M | AUD 304.21K | AUD 11.16M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-13 | AUD 26.06M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Oncosil Medical Ltd
OncoSil Medical Limited, a medical device company, develops and commercializes localised radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company offers OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Oncosil Medical Ltd's market cap?
Oncosil Medical Ltd's market capitalization is AUD 26.06M.
What does Oncosil Medical Ltd do?
OncoSil Medical Limited, a medical device company, develops and commercializes localised radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company offers OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.